medical-devices is the sole category represented across all 1 tracked stories. LENSAR is most often covered alongside Alcon, which appears in 1 of these 1 story. Source depth averages 5 original sources per story, versus 3.1 across the same-window beat baseline.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about LENSAR
medical-devices is the sole category represented across all 1 tracked stories. LENSAR is most often covered alongside Alcon, which appears in 1 of these 1 story. Source depth averages 5 original sources per story, versus 3.1 across the same-window beat baseline. The 6 average consequence score is below the beat benchmark of 6.3 in the same window. We currently track 1 Healthcare story that mention LENSAR, all published on March 17, 2026.
Stories tracked
1
Sources per story
5
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 34 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering LENSAR. Shared-story counts are live from our verified record — not editorial picks.
Alcon has officially terminated its merger agreement with LENSAR, a leader in femtosecond laser technology, citing insurmountable opposition from the Federal Trade Commission (FTC). The collapse of the deal highlights increasing regulatory scrutiny over consolidation within the specialized medical device and ophthalmic surgery sectors.
LENSAR is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.